Jump to section
To build its platform into a generalised tool for patient selection, surgical planning and device programming for machine brain interfacing, a revolutionary therapeutic innovation.
Movement disorders such as Parkinsons affect roughly 40 million people a year, but assessing the advancement of such disorders can be difficult and often subjective. Machine Medicine supplies technology for the motor assessment of patients from video, to enable better and objective tracking of symptoms leading to more effective treatment.
Founded in 2017, Machine Medicine brings AI and computer vision into the motor assessment space. The company’s first product, Kelvin, uses video clips instead of eye-witness accounts to gauge the severity of motor diseases, eliminating the historic subjectiveness of this process. The clips can be taken on any mobile device with a camera and internet access, with videos automatically uploaded and backed up. Data and analytics can be accessed online or downloaded, with the platform boasting strong security and compliance processes in line with the sensitive nature of the data it provides.
Machine Medicine has seen good investment towards accelerating product development and is conducting research to expand its product range. There is a good amount of literature written on Kelvin by peers in the space, alongside promising conclusions, demonstrating there is interest and respect for its technology.
Steph
Company Specialist at Welcome to the Jungle
Dec 2022
$1.3m
GRANT
Apr 2019
$0.7m
SERIES A
This company has top investors
Jonathan O'Keeffe
(CEO)Graduated from the University of Oxford with a BA in Medical Science. Previously a Doctor for the NHS.